Jenburkt Pharmaceuticals Share Price

Small Cap | Pharmaceuticals and health care | BSE: 524731

₹957.70 image-0.50 (-0.05 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 970.00

High (₹) 992.95

Low (₹) 951.20

Prev. Close (₹) 958.20

Volume 719

VWAP (₹) 946.02

ROCE (%) 23.83

Industry P/E 43.95

TTM P/E 13.46

P/B Ratio 2.92

Market Cap (₹) Cr.422.66

Dividend Yield (%)1.60

EPS (₹) 58.86

ROE17.92%

Sales Growth (%) 3.82

Profit Growth (%)5.57

Day Range

992.95992.95

L
H

52 Week Range

660.051,375.00

L
H

Historical Returns

Returns (6M)

-15.14 %

Returns (1Y)

36.79 %

Returns (3Y)

74.76 %

Returns (5Y)

201.69 %

Returns (6M)

-15.14 %

Returns (1Y)

36.79 %

Returns (3Y)

74.76 %

Returns (5Y)

201.69 %

SWOT Analysis

  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 37.78

MFI 42.70

ATR 62.61

Commodity Channel Index -130.00

ROC125 -17.57

ROC21 -16.76

Williams %R -99.39

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current963.14988.221,001.44949.92924.84911.62886.54
Week Ago1,024.161,044.031,058.061,010.13990.26976.23956.36
Month Ago1,251.461,304.731,385.461,170.731,117.461,036.73983.46

EMA & SMA
info_icon

957.70

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 987.33


9 Day 996.34


10 Day 1001.16


12 Day 1019.43


14 Day 1028.08

20 Day 1055.71


26 Day 1085.14


50 Day 1156.11


100 Day 1141.41


200 Day 1039.88

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
JENBURKT PHARMACEUTICALS LTDbulkBuy06 Jan, 2023₹649.9747,037BSE
ARIES STOCKTRADES PVT LTD A/C-PMSbulkSell25 Aug, 2020₹410.3926,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
14 Jun, 2024PRAKASH H. BhutaDisposal₹804.7920,473BSE
27 Mar, 2024Prakash BhutaDisposal₹702.215,931BSE
10 Jul, 2023MAHESH H BHUTADisposal2,500BSE
10 Jul, 2023MAHESH H BHUTAAcquisition2,500BSE
10 Jul, 2023MAHESH H BHUTADisposal₹716.051,000BSE
29 May, 2023RIDDHI HARESH SHROFFAcquisition14,707BSE
29 May, 2023RIDDHI HARESH SHROFFDisposal14,707BSE
26 Apr, 2023RIDDHI HARESH SHROFFAcquisition14,707BSE
26 Apr, 2023RIDDHI HARESH SHROFFDisposal14,707BSE
11 Nov, 2022RIDDHI HARESH SHROFFAcquisition14,707BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
28 May, 2024Rs.15.3000 per share(153%)Dividend23 Jul, 202401 Jan, 1970
23 May, 2023Rs.14.4000 per share(144%)Dividend19 Jul, 202301 Jan, 1970
27 May, 2022Rs.12.0000 per share(120%)Final Dividend21 Jul, 202201 Jan, 1970

Announcements

DateSourceDetail
03 Mar, 2025BSE IndiaIntimation of acquisition of land close to the existing plant at Sihor, Gujarat.
28 Jan, 2025BSE IndiaIntegrated Filing (Financial) for the quarter and nine months ended on 31st December, 2024.
28 Jan, 2025BSE IndiaStandalone Unaudited Financial Results for the quarter and nine months ended on 31st December, 2024.
28 Jan, 2025BSE IndiaOutcome of the Board Meeting held today on 28th January, 2025, inter-alia to approved standalone unaudited financial results for the quarter and nine months ended on 31st December,2024.
20 Jan, 2025BSE IndiaJENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 ,inter alia, to consider and approve unaudited financial results for the quarter and nine months ended on 31st December, 2024.
05 Nov, 2024BSE IndiaOutcome of Board Meeting held today on 05-11-2024, inter-alia to approved Standalone Unaudited Financial Results For The Quarter and half year Ended On 30Th September, 2024.
05 Nov, 2024BSE Indiastandalone Unaudited Financial Results for the quarter and half year ended on 30th September, 2024.
28 Oct, 2024BSE IndiaJENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2024 ,inter alia, to consider and approve Standalone unaudited financial results for the quarter and half year ended on 30th September, 2024.
09 Oct, 2024BSE IndiaCertificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations, 2018 for the quarter ended on 30.09.2024.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--21 Jan, 202528 Jan, 2025
Quarterly Results--29 Oct, 202405 Nov, 2024
Quarterly Results--19 Jul, 202426 Jul, 2024
Audited Results & Dividend--22 May, 202428 May, 2024
Quarterly Results--20 Jan, 202406 Feb, 2024
Quarterly Results--30 Oct, 202307 Nov, 2023
Quarterly Results--27 Jul, 202308 Aug, 2023
Audited Results, Dividend & A.G.M.--15 May, 202323 May, 2023
Quarterly Results--30 Jan, 202307 Feb, 2023
Buy Back of Shares--29 Nov, 202201 Dec, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Jenburkt Pharmaceuticals

Jenburkt Pharmaceuticals is a Public Limited Listed company incorporated on 10/06/1985 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1985PLC036541 and registration number is 036541. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 141.97 Cr. and Equity Capital is Rs. 4.41 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1985

Managing Director

Mr. Ashish U Bhuta

NSE Symbol

--

Jenburkt Pharmaceuticals Management

NameDesignation
Mr. Ashish U BhutaChairman & Managing Director
Mr. Dilip H BhutaWholeTime Director & CFO
Mrs. Hina R MehtaInd. Non-Executive Director
Mr. Sumit A ThakkarInd. Non-Executive Director
Mr. Krishnan SubharamanInd. Non-Executive Director
Mr. Pankaj A DantwalaInd. Non-Executive Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Jenburkt Pharmaceuticals

What is the share price of Jenburkt Pharmaceuticals?

The share price of Jenburkt Pharmaceuticals on 13 Mar, 2025 is ₹ 957.70.

What is 52W high and 52W low share price of Jenburkt Pharmaceuticals?

The highest and lowest 52W share prices of Jenburkt Pharmaceuticals are ₹ 1375.000 and ₹ 660.050

What is the market cap of Jenburkt Pharmaceuticals?

The market capitalization of Jenburkt Pharmaceuticals as of 13 Mar, 2025 is ₹ 422.66 Crores

What is the P/E ratio of Jenburkt Pharmaceuticals?

The current P/E ratio of Jenburkt Pharmaceuticals as of 13 Mar, 2025 is 43.95

What is the PB ratio of Jenburkt Pharmaceuticals?

The PB ratio of Jenburkt Pharmaceuticals as of 13 Mar, 2025 is 2.92

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited